Geode Capital Management, LLC Cti Biopharma Corp Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$4.2 - $6.01 $487,309 - $697,316
116,026 Added 6.06%
2,029,780 $8.53 Million
Q4 2022

Feb 13, 2023
BUY
$4.45 - $6.17 $599,793 - $831,623
134,785 Added 7.58%
1,913,754 $11.5 Million
Q3 2022

Nov 14, 2022
BUY
$5.36 - $7.43 $1.02 Million - $1.41 Million
190,422 Added 11.99%
1,778,969 $10.4 Million
Q2 2022

Aug 12, 2022
BUY
$3.55 - $6.27 $2.88 Million - $5.08 Million
810,931 Added 104.28%
1,588,547 $9.48 Million
Q1 2022

May 13, 2022
BUY
$1.9 - $5.23 $180,481 - $496,797
94,990 Added 13.92%
777,616 $3.63 Million
Q4 2021

Feb 11, 2022
BUY
$1.44 - $2.86 $34,272 - $68,068
23,800 Added 3.61%
682,626 $1.69 Million
Q3 2021

Nov 12, 2021
BUY
$2.25 - $3.18 $156,771 - $221,569
69,676 Added 11.83%
658,826 $1.94 Million
Q2 2021

Aug 13, 2021
BUY
$2.16 - $2.62 $230,044 - $279,035
106,502 Added 22.07%
589,150 $1.47 Million
Q1 2021

May 12, 2021
BUY
$2.68 - $3.8 $138,199 - $195,954
51,567 Added 11.96%
482,648 $1.4 Million
Q4 2020

Feb 12, 2021
BUY
$2.48 - $3.8 $36,317 - $55,647
14,644 Added 3.52%
431,081 $1.39 Million
Q3 2020

Nov 13, 2020
SELL
$1.02 - $2.15 $7,290 - $15,368
-7,148 Reduced 1.69%
416,437 $895,000
Q2 2020

Aug 13, 2020
BUY
$0.88 - $1.32 $6,663 - $9,995
7,572 Added 1.82%
423,585 $491,000
Q1 2020

May 14, 2020
BUY
$0.69 - $1.54 $9,846 - $21,975
14,270 Added 3.55%
416,013 $382,000
Q4 2019

Feb 13, 2020
SELL
$0.72 - $1.64 $34,567 - $78,738
-48,011 Reduced 10.67%
401,743 $634,000
Q3 2019

Nov 12, 2019
SELL
$0.64 - $0.92 $4,416 - $6,348
-6,900 Reduced 1.51%
449,754 $374,000
Q2 2019

Aug 14, 2019
SELL
$0.8 - $1.03 $139,567 - $179,692
-174,459 Reduced 27.64%
456,654 $392,000
Q1 2019

May 14, 2019
SELL
$0.9 - $1.37 $1,452 - $2,211
-1,614 Reduced 0.26%
631,113 $612,000
Q4 2018

Feb 13, 2019
BUY
$0.73 - $2.19 $3,806 - $11,418
5,214 Added 0.83%
632,727 $464,000
Q3 2018

Nov 13, 2018
BUY
$1.72 - $5.24 $196,578 - $598,879
114,290 Added 22.27%
627,513 $1.36 Million
Q2 2018

Aug 14, 2018
BUY
$3.81 - $5.26 $800,077 - $1.1 Million
209,994 Added 69.25%
513,223 $2.56 Million
Q1 2018

May 15, 2018
BUY
$2.7 - $4.06 $496,373 - $746,398
183,842 Added 153.99%
303,229 $1.18 Million
Q4 2017

Feb 13, 2018
SELL
$2.47 - $3.34 $185,986 - $251,495
-75,298 Reduced 38.68%
119,387 $319,000
Q3 2017

Nov 14, 2017
BUY
$3.12 - $3.65 $252,729 - $295,660
81,003 Added 71.25%
194,685 $620,000
Q2 2017

Aug 14, 2017
BUY
N/A
113,682
113,682 $376,000

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email